A common strategy for studying the biological role of deubiquitinating enzymes (DUBs) in different pathways is to study the effects of replacing the wild type DUB with a catalytically inactive mutant in cells. We report here that a commonly studied DUB mutation, in which the catalytic cysteine is replaced with alanine, can dramatically increase the affinity of some DUBs for ubiquitin. Overexpression of these tight-binding mutants thus has the potential to sequester cellular pools of monoubiquitin and ubiquitin chains. As a result, cells expressing these mutants may display unpredictable dominant negative physiological effects that are not related to loss of DUB activity. The structure of the SAGA DUB module bound to free ubiquitin reveals the structural basis for the 30-fold higher affinity of Ubp8 C146A for ubiquitin. We show that an alternative option, substituting the active site cysteine with arginine, can inactivate DUBs while also decreasing the affinity for ubiquitin. 3
Introduction
Deubiquitinating enzymes (DUBs) play fundamental roles in ubiquitin signaling through their ability to remove ubiquitin from target proteins and disassemble polyubiquitin chains [1] . These enzymes cleave the isopeptide linkage between the C-terminus of ubiquitin and the substrate lysine or, in some cases, the peptide bond between ubiquitin and a substrate protein N-terminus. The human genome encodes more than 90 DUBs, which can be grouped into families based on their fold: ubiquitin-specific protease (USP), ubiquitin carboxy-terminal hydrolase [2] , ovarian tumor family (OTUs), Machado-Joseph domain (MJD) family, and JAMM/MPN domain (JAMMs), as well as the recently-discovered MINDY family [3] [4] [5] . Studies of deletions as well as diseasecausing mutations have revealed specific functions for individual DUBs in biological processes including proteasomal degradation, protein trafficking, transcription, DNA repair, infection and inflammation [6] [7] [8] . The involvement of DUBs in a variety of oncogenic, inflammation, and neurodegenerative pathways [9] has made these enzymes attractive targets for drug discovery [10, 11] .
A common approach to determining the role of a particular DUB in cellular pathways is to knock down expression of the endogenous DUB and express a catalytically inactive version of the enzyme. With the exception of the JAMM domain family, which are metalloproteases, all other DUBs are cysteine proteases with a classical papain-like active site in which the cysteine is activated by an adjacent histidine [12] . Cysteine protease DUBs are typically inactivated by substituting the active site cysteine with another residue. Resulting changes in substrate ubiquitination or downstream signaling pathways in cells expressing the mutant DUB are generally assumed to be due to the absence of deubiquitinating activity, with the notable exceptions of OTUB1, which inhibits E2 enzymes by a mechanism independent of catalytic activity [13] [14] [15] and OTUD4, which serves as a scaffold for USP enzymes [16] . Whereas serine is the most conservative substitution for the active site cysteine, alanine substitutions are often used to avoid the possibility that mutants containing the more conservative serine substitution may retain some hydrolase activity.
We report here that some active site cysteine to alanine substitutions can dramatically increase the affinity of DUBs for either free ubiquitin or polyubiquitin chains. This increase in affinity can confound the interpretation of in vivo experiments, since the mutant DUB is not only incapable of cleaving ubiquitin from substrates but has gained the ability to sequester free ubiquitin and polyubiquitin chains. Altering levels of free ubiquitin has been shown to give rise to off-target effects [17] . In addition, these mutant DUBs may stably associate with (poly)ubiquitinated substrates and thereby protect ubiquitin chains from cleavage by other DUBs or prevent interaction with ubiquitin receptors. The effects of such tight-binding DUB mutants thus have the potential to be highly diverse and unpredictable. In the case of the OTU DUB, A20, for example, the phenotype of an alanine substitution created a controversy over the physiological importance of its highly conserved DUB activity, since A20 containing alanine in place of cysteine was able to complement the wild-type version [18] .
We show here that mutating the active site cysteine of human USP4 and yeast Ubp8 to alanine increases the affinity of the DUB for mono- or di-ubiquitin by 10 - 150 fold. A similar effect of alanine substitution was previously found for the OTU enzyme, Cezanne (reference [19] , supplementary data). The structure of the heterotetrameric SAGA DUB module containing Ubp8 C146A bound to free ubiquitin reveals the molecular basis for the increased affinity of monoubiquitin for the mutant enzyme. The alanine substitution alleviates steric hindrance by the active site cysteine sulfhydryl, allowing the C-terminal carboxylate of ubiquitin to form additional hydrogen bonds in the enzyme active site and thus accounts for the high affinity of the mutant enzyme for free ubiquitin.
We show that substituting the active site cysteine of representative USP and OTU DUBs with arginine inactivates the enzymes while also disrupting binding to ubiquitin, generating an inert DUB domain. Based on these findings we strongly recommend that cell-based and in vivo studies of DUBs avoid the use of active site alanine substitutions, and to instead utilize substitutions such as arginine that ablate both enzymatic activity and ubiquitin binding.
RESULTS

Mutation of active site cysteine to alanine increases affinity of the SAGA DUB module for ubiquitin
The yeast SAGA complex is a transcriptional coactivator that is involved in regulating mRNA transcription [20] . Among its activities is the removal of monoubiquitin from histone H2B, which promotes transcription initiation and elongation [21] . The deubiquitinating activity of SAGA resides in a four-protein complex known as the DUB module, which comprises the USP family catalytic subunit, Ubp8, as well as Sgf11, Sus1 and the N-terminal ~100 residues of Sgf73 [22, 23] . Structural studies of the DUB module complexed with ubiquitin aldehyde and ubiquitinated nucleosomes have revealed the overall organization of the DUB module and how in interacts with substrate [24, 25] . In addition to its ability to deubiquitinate histone H2B, the DUB module can also cleave a variety of ubiquitin substrates in vitro including ubiquitin AMC and K48-linked diubiquitin [26] . In order to measure the affinity of the DUB module for other substrates using binding assays, we expressed and purified catalytically inactive versions of the DUB module containing Ubp8 with its active site cysteine, C146, substituted with either serine (C146S) or alanine (C146A). The absence of catalytic activity for both mutants was first verified in a ubiquitin-AMC cleavage assay (Fig.  S1 ). We then measured the affinity of both mutant complexes for K48-linked diubiquitin using isothermal titration calorimetry (ITC) ( Fig.  1E-F Crystal structure of DUBm-Ubp8 C146A with Ub
To determine the structural basis for the marked increase in affinity for free ubiquitin when the active site cysteine is substituted with alanine, we solved the crystal structure of the SAGA DUB module containing Ubp8 C146A bound to free ubiquitin at a resolution of 2.1 Å (Table  1 and Fig.  2A ). The overall fold and contacts with ubiquitin are virtually identical to those found in the structure of the wild type enzyme bound to ubiquitin aldehyde, aligning to an RMSD of 0.57 Å [24] . The active site of the C146A mutant is virtually identical to that in the wild type apoenzyme [26] , with no significant reordering of residues ( Fig.  2B ) [26] . In the Ubp8 C146A complex with free ubiquitin, the negatively charged carboxylate of the ubiquitin C-terminal Gly76 forms two hydrogen bonds with backbone amides from Ubp8 residues Thr145 and Ala146, as well as with active site residues, N146 and H427 ( Fig.  2B  and  S2 ). Importantly, the observed position of the ubiquitin C-terminus would not be compatible with the presence of the wild-type active site residue, Cys146, since the sulfhydryl group would clash with the C-terminal residue of ubiquitin, Gly76 (Fig.  2C ). The multiple hydrogen bonding interactions observed between the C-terminal carboxylate of ubiquitin and Ubp8 can therefore only occur when the active Cys146 is replaced with the smaller alanine side chain, thus explaining the higher affinity of DUB module-Ubp8 C146A for free ubiquitin as compared to the wild type enzyme.
Active site cysteine to alanine substitution increases the affinity USP4 for ubiquitin
Mutating the active site cysteine to alanine has an even more dramatic effect on the affinity of the human USP family DUB, USP4, for free ubiquitin. USP4 regulates a broad variety of cellular pathways, including TGF-β and NF-κB signaling as well as splicing [23, 27, 28] . The affinity of USP4 for free ubiquitin was measured by fluorescence polarization using ubiquitin labeled with an N-terminal fluorophore. As shown in Figure 3 , the K d of ubiquitin for the wild type enzyme is 92 ± 21 nM whereas USP4 containing an alanine substituted for the active site cysteine, C311, binds ubiquitin with 0.60 ± 0.17 nM affinity, a ~150-fold difference [29] . The pre-steady-state kinetics of ubiquitin dissociation measured by fluorescence polarization in a stopped-flow device shows that the greater affinity of the USP4 C311A mutant is due to a dramatic decrease in off-rate (Fig.  S3A) . Interestingly, ubiquitin dissociation has been shown to be promoted by USP4 N-terminal DUSP-Ubl domain and to regulate USP4 activity [29] . The increase in affinity for the mutant enzyme is not unique to ubiquitin with a free C-terminus, as ubiquitin conjugated to either an 18-mer peptide or C-terminal fluorophore also binds with similar affinity to USP4 C311A ( Fig.  S3C-D) . Since the active sites of USP family DUBs are highly conserved, the increase in binding affinity is due a relief of steric clash, as is the case for Ubp8.
Substitution of the catalytic cysteine with arginine disrupts ubiquitin binding in USP and OTU class DUBs
We sought to identify alternative active site mutations that would abrogate catalytic activity as well as reduce the affinity of the inactive DUB polyubiquitin chains or ubiquitinated substrates. We reasoned that substituting the active site cysteine with arginine could both inactivate the enzyme and prevent ubiquitin binding because of the bulky nature of the side chain compared to cysteine. To test this hypothesis, we mutated the catalytic cysteine of Ubp8 to arginine and first verified that SAGA DUB module containing the mutant Ubp8 C146R protein was inactive in a Ub-AMC cleavage assay (Fig.  S1 ). The affinity of the DUB module containing Ubp8 C146R for monoubiquitin as measured by ITC was comparable to that of the wild type protein (Fig.  1D) .
Substitution of the active cysteine with arginine similarly reduces the affinity for polyubiquitin chains by the OTU family member, OTUD1, which is also a cysteine protease. This DUB preferentially cleaves K63-linked polyubiquitin chains [19] , although the cellular function of this activity remains an area of active study. We measured the affinity of catalytic mutants of OTUD1 for fluorescently labelled K63-linked diubiquitin using a fluorescence polarization assay. While OTUD1 with an alanine substituted for 8 the active site cysteine (OTUD1 C320A ) binds K63-linked diubiquitin with a K d of ~40 µM, an arginine substitution, OTUD1 C320R , not only inactivated the enzyme but also completely abolished detectable binding to K63-linked diubiquitin (Fig.  4) .
OTUD1 active site arginine substitution overcomes artifacts of alanine substitution in cells
As mentioned above, active site cysteine to alanine substitutions that markedly increase DUB affinity for mono or polyubiquitin may render these mutants less suitable for physiological studies. Since these cysteine to alanine mutants are essentially highaffinity ubiquitin binding proteins, these mutants could stabilize modified substrates and preferred chain types by protecting them from digestion by other DUBs or proteases. (Fig.  5) . These results are consistent with the idea that the increase in polyubiquitin chains observed in the C320A mutant is due to the ability of this mutant to bind to polyubiquitin chains and protect them from cleavage by other DUBs. Our results also validate the utility of using a Cys to Arg substitution to generate a catalytically inactive DUB that will neither protect nor sequester polyubiquitin chains and ubiquitinated substrates.
Discussion
The surprisingly high affinity for ubiquitin exhibited by DUBs containing alanine substituted for the active site cysteine has important implications for cell-based assays in which catalytically inactive DUBs are expressed. We have found that cysteine to alanine substitutions in the USP DUBs, Ubp8 and USP4, dramatically increases their affinity for monoubiquitin (Figs.  1  and  3) . Similarly, cysteine to alanine substitutions in the active sites of Ubp8 and the OTU class DUB, OTUD1, also increase DUB affinity for polyubiquitin ( Figs.  1  and  4) . The equilibrium dissociation constants of these mutant DUBs are significantly lower than cellular concentrations of their substrates, with an estimated concentration of free ubiquitin in the cell of 4 - 50 µM [30] and a concentration of polyubiquitin at a fraction of that [31] . The mutant DUBs are therefore expected to bind avidly to free ubiquitin and polyubiquitin chains when expressed in cells. Particularly in experiments where the mutant DUBs are overexpressed, there is the risk that cellular consequences ascribed to a lack of catalytic activity in a particular DUB may instead be due to the ability of the mutant DUB to protect polyubiquitin chains from cleavage or to a difference in free ubiquitin available to ubiquitin conjugating enzymes.
We have presented an alternative to alanine substitutions that is equally effective in abrogating DUB activity while having the advantage of preventing ubiquitin binding. In binding assays of Ubp8 and OTUD1, we show that replacing the active site cysteine with arginine inactivates ubiquitin hydrolase activity while also rendering the enzyme incapable of binding ubiquitin detectably (Figs.  1D  and  4) . We speculate that the ability of arginine substitutions to abolish ubiquitin binding to OTU and USP catalytic domains may be explained by the ability of the arginine side chain to partially occupy the binding site for the C-terminal ubiquitin Gly-Gly in these DUBs. Previous data has indicated that the correct orientation of the ubiquitin C-terminal tail in the DUB S1 site is essential for efficient cleavage [32, 33] . An arginine side chain may mimic these interaction in cis, to prevent these important substrate interactions.
While we did not test other active site substitutions, it is expected that other amino acids with side chains that are significantly bulkier than cysteine would similarly block ubiquitin binding in addition to inactivating the enzyme. However, care should be taken to avoid hydrophobic side chains that could cause the protein to aggregate, or side chains that are bulky or beta-branched that could interfere with proper protein folding due to steric clashes with the neighboring protein backbone. Since lysine can be ubiquitinated and is also subject to many other post-translational modifications, this substitution should also be avoided.
We recommend that all cell-based and in vivo studies of cysteine protease DUBs avoid alanine substitutions of the active site cysteine and instead utilize arginine substitutions to study effects of inactivating the enzyme. Although the arginine substitution was only tested here on DUBs from the USP and OTU class, it is possible that an arginine would similarly interfere with ubiquitin binding to members of the UCH, MJD, and MINDY cysteine protease families, in addition to inactivating the enzyme. Adopting this practice can mitigate any spurious, off-target effects and ensure that any observed phenotypes or changes are due to loss of DUB activity alone rather than an increase in affinity for ubiquitin.
Materials and Methods
Cloning, protein expression and purification
Rosetta 2(DE3) pLysS cells (EMD Millipore, Merck KGaA, Darmstadt, Germany) were transformed with three plasmids encoding (1) Ubp8 WT , Ubp8 C146A , Ubp8 C146S or Ubp8 C146R (pET-32a, EMD Millipore), (2) Sus1 (pRSF-1, EMD Millipore), and (3) Sgf73 , (pCDFDuet-1 MCSII, EMD Millipore), which was cloned into the same vector as Sgf11 (pCDFDuet-1 MCSI, EMD Millipore). All versions of the DUBm complex were coexpressed and purified using the previously reported protocol for the expression and purification of wild-type DUBm [24] . Untagged ubiquitin (pET3a) was expressed in Rosetta 2 cells and after lysis, was treated with 1% v/v perchloric acid to precipitate cellular proteins. The supernatant, containing ubiquitin, was dialyzed overnight into 50 mM sodium acetate pH 4.5, then run on a HiTrap SP column and eluted over a 0 - 600 mM NaCl gradient in 50 mM sodium acetate pH 4.5. Pure fractions were pooled and buffer exchanged by gel filtration on a HiLoad S75 column into 20 mM HEPES pH 7.5, 50 mM NaCl, 1 mM DTT.
USP4(8-925) wild-type and C311A mutant were expressed and purified as in [29] .
pOPINK-OTUD1 catalytic domain (residues 287-435) was transformed into E.coli Rosetta 2 pLysS (Novagen) and grown to OD 0.6 followed by induction with 0.2 mM IPTG overnight at 20°C. Cells were lysed by sonication in buffer A (50 mM Tris, 50 mM NaCl, 5 mM DTT, pH 8.5), the lysate was cleared by centrifugation (44000 x g for 30 min, 4°C) and subjected to a glutathione resin (GE Healthcare). The resin was washed with cold buffer B buffer (50 mM Tris, 500 mM NaCl, 5 mM DTT, pH 8.5) and subsequently with cold buffer A. The GST-tag was removed by overnight incubation at 4°C with GST-tagged 3C Precision protease in buffer A. Eluted protein was further purified by anion-exchange chromatography and gel filtration in buffer A.
Fluorescence Polarization Assays
All USP4 pre-steady-state and equilibrium fluorescence polarization assays were performed as described in [29] . Ubiquitin conjugated to lysine-glycine and to a SMAD4-derived peptide [29] were a gift of Huib Ovaa.
Binding assays for OTUD1 interactions with Lys63-linked chains were performed using Lys63-linked diUb that was fluorescently labeled by a FlAsH-tag on the proximal ubiquitin (21) . For this, diUb chains were diluted to 80 nM in FlAsH buffer (50 mM Tris, 50 mM NaCl, 0.1% β-mercaptoethanol, pH 7.6), and OTUD1 C320A and OTUD1 C320R were serially diluted in FlAsH buffer to the indicated concentration range. 10 µl of fluorescent diUb was mixed with equal volume of OTUD1 C320A and OTUD1 C320R at different concentrations and incubated in room temperature for 1 h before measurement.
Fluorescence polarization was measured in 384 well format employing a Pherastar FS plate reader, using a fluorescence polarization module with excitation and emission wavelengths at 485 nm and 520 nm respectively. A control was used for either linear dior triUb molecules where 10 µl of FlAsH buffer was added instead. This control was also used for the normalization of anisotropy reading. All binding assays were performed in triplicate.
Ubiquitin-AMC hydrolysis Assay
Assays were conducted in 384-well black polystyrene micro-plates at 30°C in a POLARstar Omega plate reader (BMG Labtech, Cary, NC) using an excitation wavelength of 385 nm and emission wavelength of 460 nm. Reactions were performed in DUBm assay buffer containing 50 mM HEPES, pH 7.6, 150 mM NaCl, 5µM ZnCl 2 , 5 mM dithiothreitol (DTT) and 7.5% DMSO. The wild type DUBm and Ubp8 mutants were held at a concentration of 125 nM. Ubiquitin-AMC (Boston Biochem, Cambridge, MA) was diluted into assay buffer and incubated at 30°C for 10 min inside the plate reader. 3 μl of recombinant DUBm was also pre-incubated at 30°C for 10 min before mixing with diluted ubiquitin-AMC buffer to a total volume of 30 μl. The release of AMC was followed at 460 nm, and the first 0-60 s of data were used to fit initial rate.
Aimless [34] ). A 2.1 Å structure was determined by molecular replacement in Phaser (Phenix) using the coordinates of the wild-type DUBm bound to ubiquitin aldehyde (PDB ID: 3MHS) as the search model [24, 35] . The structure was refined in PHENIX and Coot was used for manual model building [35, 36] . Data collection and refinement statistics are shown in Table  1 Samples were subsequently cleared by centrifugation for 10 min at 16,000 x g at 4°C.
For immunoblotting, equivalent amounts of cell lysates were separated on 4-12% BisTris gel, transferred to nitrocellulose membranes, and incubated with the indicated antibodies. The signal was visualized with Pierce ECL Western Blotting Substrate (Thermo Scientific) and exposed on X-ray film.
Antibodies
The following antibodies were used in immunoblotting or immunoprecipitation: rat monoclonal anti-HA (clone 3F10, Sigma-Aldrich), rabbit monoclonal anti-Ub K63 (clone Apu3, Millipore) and mouse anti-GAPDH (clone D4C6R, Cell Signaling). WT structure is shown in teal (PDB ID 3MHH) and DUBm-Ubp8 C146A is shown in green. 
Supplementary Figures
Figure S1 
